Johnson Faye, Phillips Dafydd, Talabani Bnar, Wonnacott Alexa, Meran Soma, Phillips Aled O
Insititute of Nephrology, Cardiff University School of Medicine, Cardiff, UK.
Nephrology (Carlton). 2016 Jun;21(6):506-11. doi: 10.1111/nep.12649.
Little data exist on outcome of acute kidney injury (AKI) in diabetes. We describe short-term recovery of renal function, patient mortality and progressive renal dysfunction following AKI in diabetic patients.
Using the diagnosis of either diabetes or no diabetes as the defining variable, AKI episodes were identified from records of a clinical biochemistry department serving a population of 560 000. Patient co-morbidity and mortality were collated from electronic patient records. Outcomes were compared with a non-diabetic cohort with AKI.
Acute kidney injury was identified in 101 diabetic and 392 non-diabetic patients. Patients with diabetes had less severe AKI, compared with the non-diabetic cohort (AKI stage 1 76% vs 55%, P = 0.0006). Overall acute mortality, and mortality adjusted for co-morbidity, was comparable in the diabetic and non-diabetic groups. Recovery to baseline renal function was greater in diabetic patients (87% vs 63% P = 0.001), and the proportion of patients developing progressive chronic kidney disease was lower in the (14%) compared with the non-diabetic cohort (48%, P < 0.00001).
Although acute mortality is comparable following an AKI episode in diabetic patients compared with that associated with AKI in a non-diabetic cohort, for those surviving the acute episode, its impact on renal function is significantly less than in a non-diabetic group.
关于糖尿病患者急性肾损伤(AKI)的预后数据较少。我们描述了糖尿病患者急性肾损伤后肾功能的短期恢复情况、患者死亡率及进行性肾功能障碍。
以糖尿病诊断与否作为定义变量,从一个服务于56万人口的临床生化科记录中识别急性肾损伤发作情况。从电子病历中整理患者的合并症和死亡率。将结果与非糖尿病急性肾损伤队列进行比较。
在101例糖尿病患者和392例非糖尿病患者中识别出急性肾损伤。与非糖尿病队列相比,糖尿病患者的急性肾损伤严重程度较低(急性肾损伤1期:76%对55%,P = 0.0006)。糖尿病组和非糖尿病组的总体急性死亡率以及经合并症调整后的死亡率相当。糖尿病患者恢复至基线肾功能的比例更高(87%对63%,P = 0.001),并且糖尿病患者发生进行性慢性肾病的比例(14%)低于非糖尿病队列(48%,P < 0.00001)。
尽管糖尿病患者急性肾损伤发作后的急性死亡率与非糖尿病队列中急性肾损伤相关的死亡率相当,但对于急性发作后存活的患者,其对肾功能的影响明显小于非糖尿病组。